Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2010, 78(3), 675; https://doi.org/10.3797/scipharm.cespt.8.PNM05 (registering DOI)
Fibrin Targeting with Ultrasound Active Antibody-Conjugated Liposomes
Department of Pharmaceutical Technology and Biopharmaceutics, Philipps-Universität, Marburg, Germany
Department of neuro surgery, Universitätsklinikum Gießen und Marburg GmbH, Philipps-Universität, Marburg, Germany
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Abstract Blood vessel diseases like antherosclerosis lead to formation of blood clots with severe consequences like acute ischemic stroke or myocardial infarction . [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
MARXER, E.E.J.; BRÜßLER, J.; BECKER, A.; NIMSKY, C.; BAKOWSKY, U. Fibrin Targeting with Ultrasound Active Antibody-Conjugated Liposomes. Sci. Pharm. 2010, 78, 675.
MARXER EEJ, BRÜßLER J, BECKER A, NIMSKY C, BAKOWSKY U. Fibrin Targeting with Ultrasound Active Antibody-Conjugated Liposomes. Scientia Pharmaceutica. 2010; 78(3):675.
MARXER, E. E. J.; BRÜßLER, J.; BECKER, A.; NIMSKY, C.; BAKOWSKY, U. 2010. "Fibrin Targeting with Ultrasound Active Antibody-Conjugated Liposomes." Sci. Pharm. 78, no. 3: 675.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.